Merck & Co.
213 E Grand Avenue, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA 02141
United States
4224 articles about Merck & Co.
-
Codexis, Inc. and Merck & Co., Inc. Develop Prototype Enzyme-Based Method for Production of Boceprevir
4/4/2012
-
Randy Jackson Partners with Merck & Co., Inc. to Urge People with Type 2 Diabetes to Take Their Diabetes to Heart
4/3/2012
-
GlaxoSmithKline's New Once-daily HIV Drug Matches Merck & Co., Inc. Rival
4/2/2012
-
Efficacy and Safety Data for ZOSTAVAX® (Zoster Vaccine Live), Merck & Co., Inc.'s Shingles Vaccine, in Adults Ages 50 to 59 Published in Clinical Infectious Diseases
4/2/2012
-
Merck & Co., Inc. Appoints Michael J. Holston as Chief Ethics and Compliance Officer
3/28/2012
-
Merck & Co., Inc. to Hold First-Quarter 2012 Sales and Earnings Conference Call on April 27
3/27/2012
-
Merck & Co., Inc. Release: VICTRELIS(TM) Now Available for Eligible Patients in British Columbia
3/27/2012
-
Inovio Pharmaceuticals Appoints Retired Merck Vaccines President Dr. Adel Mahmoud to its Board of Directors
3/27/2012
-
Merck & Co., Inc.'s Vorapaxar in Limbo After Mixed Results
3/26/2012
-
Merck & Co., Inc. Plans $100 Million Quebec Pharmaceutical Fund
3/23/2012
-
Merck & Co., Inc. Flushing Drug May Tackle Baldness
3/23/2012
-
FDA Panel Rejects Ariad Pharmaceuticals, Inc., Merck & Co., Inc. Cancer Drug for Sarcoma Patients
3/22/2012
-
Merck & Co., Inc. Returns to SD, Pouring $90 Million Into New Schultz-Led Institute
3/19/2012
-
FDA Staff Questions Benefits of GlaxoSmithKline, Merck & Co., Inc. Cancer Drugs
3/19/2012
-
Cardiome Pharma Corp. Falls as Merck & Co., Inc. Ditches Heart Development Pact
3/19/2012
-
Merck & Co., Inc. Cancer Drug Attacks Hidden HIV
3/16/2012
-
Numerate Forms Drug Discovery Collaboration with Merck & Co., Inc. to Utilize Numerate’s In Silico Drug Design Technology
3/14/2012
-
Former Merck & Co., Inc. Unit, Okairos AG Works on First Vaccine for Hepatitis C
3/14/2012
-
Merck & Co., Inc. to Present at the Barclays Capital 2012 Global Healthcare Conference
3/13/2012
-
Elsevier Business Intelligence Hosts the 9th Annual Pharmaceutical Strategic Outlook (PSO) Conference on Biopharma Strategic Dealmaking With Keynote Speakers from Elsevier Business Intelligence and Merck & Co., Inc., Grand Hyatt New York, April 11-13 2012
3/13/2012